Though many children infected with COVID-19 experience mild symptoms or are asymptomatic, a small subset develop a dangerous complication called MIS-C, or multisystem inflammatory syndrome in children, after being infected by the virus. In a study of children who received a COVID-19 vaccine after recovering from MIS-C, researchers at Baylor College of Medicine and Texas Children’s Hospital found that the vaccine was well-tolerated in this group of patients and there were no serious adverse side effects from the vaccine. Their report appears today in JAMA Network Open.
Study shows safety of vaccinating children against COVID-19 after previous MIS-C diagnosis
Though many children infected with COVID-19 experience mild symptoms or are asymptomatic, a small subset develop a dangerous complication called MIS-C, or multisystem inflammatory syndrome in children, after being infected by the virus. In a study of children who received a COVID-19 vaccine after recovering from MIS-C, researchers at Baylor College of Medicine and Texas Children's Hospital found that the vaccine was well-tolerated in this group of patients and there were no serious adverse side effects from the vaccine. Their report appears today in JAMA Network Open.